233 related articles for article (PubMed ID: 20500690)
1. Complement factor C5a in acute exacerbation of Chronic Obstructive Pulmonary Disease.
Marc MM; Kristan SS; Rozman A; Kern I; Flezar M; Kosnik M; Korosec P
Scand J Immunol; 2010 May; 71(5):386-91. PubMed ID: 20500690
[TBL] [Abstract][Full Text] [Related]
2. [Changes of anaphylatoxin C5a in chronic obstructive pulmonary disease and the relationship with systemic and local inflammation].
Zhang J; Yao WZ; Sun YC
Zhonghua Jie He He Hu Xi Za Zhi; 2008 May; 31(5):356-9. PubMed ID: 18953960
[TBL] [Abstract][Full Text] [Related]
3. Complement factors c3a, c4a, and c5a in chronic obstructive pulmonary disease and asthma.
Marc MM; Korosec P; Kosnik M; Kern I; Flezar M; Suskovic S; Sorli J
Am J Respir Cell Mol Biol; 2004 Aug; 31(2):216-9. PubMed ID: 15039137
[TBL] [Abstract][Full Text] [Related]
4. Airway angiogenesis in stable and exacerbated chronic obstructive pulmonary disease.
Kristan SS; Marc MM; Kern I; Flezar M; Suskovic S; Kosnik M; Korosec P
Scand J Immunol; 2012 Jan; 75(1):109-14. PubMed ID: 21916917
[TBL] [Abstract][Full Text] [Related]
5. Systemic CD4+ T-cell activation is correlated with FEV1 in smokers.
Glader P; von Wachenfeldt K; Löfdahl CG
Respir Med; 2006 Jun; 100(6):1088-93. PubMed ID: 16246539
[TBL] [Abstract][Full Text] [Related]
6. Decreased sputum mature dendritic cells in healthy smokers and patients with chronic obstructive pulmonary disease.
Tsoumakidou M; Bouloukaki I; Koutala H; Kouvidi K; Mitrouska I; Zakynthinos S; Tzanakis N; Jeffery PK; Siafakas NM
Int Arch Allergy Immunol; 2009; 150(4):389-97. PubMed ID: 19571571
[TBL] [Abstract][Full Text] [Related]
7. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory response in acute viral exacerbations of COPD.
Rohde G; Borg I; Wiethege A; Kauth M; Jerzinowski S; An Duong Dinh T; Bauer TT; Bufe A; Schultze-Werninghaus G
Infection; 2008 Oct; 36(5):427-33. PubMed ID: 18795228
[TBL] [Abstract][Full Text] [Related]
9. MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation.
Mercer PF; Shute JK; Bhowmik A; Donaldson GC; Wedzicha JA; Warner JA
Respir Res; 2005 Dec; 6(1):151. PubMed ID: 16372907
[TBL] [Abstract][Full Text] [Related]
10. Changes in sputum T-lymphocyte subpopulations at the onset of severe exacerbations of chronic obstructive pulmonary disease.
Tsoumakidou M; Tzanakis N; Chrysofakis G; Kyriakou D; Siafakas NM
Respir Med; 2005 May; 99(5):572-9. PubMed ID: 15823454
[TBL] [Abstract][Full Text] [Related]
11. Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers.
Shaker SB; von Wachenfeldt KA; Larsson S; Mile I; Persdotter S; Dahlbäck M; Broberg P; Stoel B; Bach KS; Hestad M; Fehniger TE; Dirksen A
Clin Respir J; 2008 Jan; 2(1):17-25. PubMed ID: 20298300
[TBL] [Abstract][Full Text] [Related]
12. [The expression and implications of human alpha-defensin 1-3 in serum and induced sputum in patients with chronic obstructive pulmonary disease].
Wang Z; Yao WZ; Xia GG; Sun DJ
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jun; 31(6):410-3. PubMed ID: 19031798
[TBL] [Abstract][Full Text] [Related]
13. Relationship between airway colonization, inflammation and exacerbation frequency in COPD.
Tumkaya M; Atis S; Ozge C; Delialioglu N; Polat G; Kanik A
Respir Med; 2007 Apr; 101(4):729-37. PubMed ID: 17002892
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients.
Droemann D; Goldmann T; Tiedje T; Zabel P; Dalhoff K; Schaaf B
Respir Res; 2005 Jul; 6(1):68. PubMed ID: 16004610
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 8-isoprostane and interleukin-8 in induced sputum and exhaled breath condensate from asymptomatic and symptomatic smokers.
Mazur W; Stark H; Sovijärvi A; Myllärniemi M; Kinnula VL
Respiration; 2009; 78(2):209-16. PubMed ID: 19252398
[TBL] [Abstract][Full Text] [Related]
16. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma.
Culpitt SV; Rogers DF; Traves SL; Barnes PJ; Donnelly LE
Respir Med; 2005 Jun; 99(6):703-10. PubMed ID: 15878486
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal follow-up of systemic inflammation after acute exacerbations of COPD.
Groenewegen KH; Dentener MA; Wouters EF
Respir Med; 2007 Nov; 101(11):2409-15. PubMed ID: 17644367
[TBL] [Abstract][Full Text] [Related]
18. Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease.
Gessner C; Scheibe R; Wötzel M; Hammerschmidt S; Kuhn H; Engelmann L; Hoheisel G; Gillissen A; Sack U; Wirtz H
Respir Med; 2005 Oct; 99(10):1229-40. PubMed ID: 16140223
[TBL] [Abstract][Full Text] [Related]
19. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
20. Correlates of non-thyroidal illness syndrome in chronic obstructive pulmonary disease.
Karadag F; Ozcan H; Karul AB; Yilmaz M; Cildag O
Respir Med; 2007 Jul; 101(7):1439-46. PubMed ID: 17346957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
